Krystal Biotech Q2 EPS Forecast Lowered by HC Wainwright
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Investment analysts at HC Wainwright lowered their Q2 2025 EPS estimates for shares of Krystal Biotech in a research note issued on Tuesday, May 6th. HC Wainwright analyst J. Pantginis now expects that the company will earn $1.71 per share for the quarter, down from their previous […]
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Investment analysts at HC Wainwright lowered their Q2 2025 EPS estimates for shares of Krystal Biotech in a research note issued on Tuesday, May 6th. HC Wainwright analyst J. Pantginis now expects that the company will earn $1.71 per share for the quarter, down from their previous […]
